Overview

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs). The study will also evaluate the effectiveness of ganaxolone in females with catamenial epilepsy. Catamenial epilepsy refers to a relationship between seizure frequency and a woman's menstrual cycle, where the number of seizures increases around the time of a woman's menstrual cycle.
Phase:
Phase 2
Details
Lead Sponsor:
Marinus Pharmaceuticals
Treatments:
Ganaxolone
Pregnanolone